IFNA1 and type 1 diabetes mellitus: Apha-interferon (a-IFN), on its turn, is a drug used to treat acute and chronic viral infections, neoplasias and autoimmune disorders, and it generates side effects such as psychiatric disorders, blood alterations, autoimmune disorders (thyroid diseases, type I diabetes mellitus and, more rarely, hearing loss.